ARP Global Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
ARP Global Capital's LLY Position: Q3 2026 in Review
ARP Global Capital increased its Eli Lilly (LLY) stake by 6% in Q3 2026, buying an estimated $2.01M and bringing the position to 30,001 shares worth $34.7M. The position accounts for 5.09% of the portfolio, ranked #8.
ARP Global Capital first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- ARP Global Capital held 30,001 shares of Eli Lilly worth $34.7M as of Q3 2026.
- ARP Global Capital bought 1,706 Eli Lilly shares in Q3 2026, an estimated $2.01M.
- Eli Lilly made up 5.09% of ARP Global Capital's portfolio in Q3 2026, its #8 holding.
- ARP Global Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on ARP Global Capital's 13F filing for Q3 2026, filed 13 Nov 2026.